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Abstract
Background
To our knowledge, little is known regarding whether white matter hyperintensities (WMH)
affect the prognosis of cryptogenic stroke (CS) patients. Understanding this association
may be helpful with expecting the prognosis of CS patients.
Methods
This retrospective observational study enrolled consecutive CS patients who underwent
brain MRI and comprehensive cardiac evaluation. Severe WMH was defined as Fazekas’
score3. We defined poor functional outcome as modified Rankin Scale score3 at 3
months. Long-term mortality and causes of death were identified using national death certifi-
cates and assessed by Kaplan-Meier method and regression analysis model.
Results
Among 2732 patients with first-ever ischemic stroke, 599 (21.9%) patients were classified
as having CS. After exclusions, 235 patients were enrolled and followed up for a median of
7.7 years (IQR, 6.7–9.0). Severe WMH were found in 81 (34.5%) patients. After adjust-
ments, severe WMH were an independent predictor for poor functional outcomes at 3
months (OR 5.25, 95% CI, 2.07–13.31). Subgroup analysis showed that severe WMH were
an independent predictor for long-term mortality only in younger patients (age < 65) (HR
3.11, 95% CI, 1.29–7.50), but not in older patients (HR 1.19, 95% CI, 0.63–2.23).
Conclusions
Severe WMH were independently associated with short-term functional outcomes in CS
patients and independently associated with long-term mortality in younger CS patients.
Grading WMH is of value in predicting prognosis of CS patients with young age.
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Introduction
The etiology of cryptogenic stroke (CS) is unknown in about 20 to 25% of stroke patients
despite extensive evaluation. The occurrence of CS is more common in young stroke patients
than in older patients [1]. According to stroke outcome studies, 14% to 30% of CS patients
experience recurrent stroke and 35.8% to 41% have poor short-term outcomes [2, 3]. Though
age, vascular risk factors, and infarct volume are sharing prognostic factors of all stroke sub-
types [4–6], specific prognostic factors associated with CS need to be investigated.
White matter hyperintensities (WMH) are small vessel diseases defined as patchy or conflu-
ent lesions in periventricular or subcortical areas. These lesions are usually identified by high
signal intensity in T2-weighted or fluid-attenuated inversion recovery (FLAIR) MRI [7].
WMH is strongly linked to lacunar infarction as they share common small artery pathologies
[8]. WMH is an important imaging biomarker of brain frailty [9]. Long-term prognoses of
patients with WMH are typically poor. Poor prognoses associated with WMH are reported not
only in the general patient population [10, 11], but also in stroke patients [12, 13]. Specifically,
There were several reports that WMH burden influenced prognosis in stroke subtypes of lacu-
nar infarctions and large artery atherosclerosis [14, 15].
Because WMH is a chronic process and CS is more frequent in younger patients, the
impacts of these conditions on mortality are difficult to determine through short-term follow-
up periods. In addition, since elderly stroke patients are more likely to die than younger
patients and they tend to have multiple comorbidities, it might be needed to test long-term
prognosis according to age stratification. However, little is known about the long-term prog-
nosis of CS patients with higher WMH burden according to age. In this regard, we hypothe-
sized and investigated that WMH burden is a surrogate imaging marker of long-term outcome
especially in younger CS patients.
Methods
Patients and evaluation
This was a retrospective observational study for CS patients who were prospectively enrolled in
the single center stroke registry [16]. During admission, all patients were thoroughly investigated
for medical history, clinical manifestations, and vascular risk factors. Every patient was evaluated
with 12-lead electrocardiography, chest x- ray, lipid profiles, and standard blood tests. All regis-
tered patients underwent brain imaging studies including brain computed tomography (CT) and/
or MRI. Angiographic studies using CT angiography, magnetic resonance angiography, or digital
subtraction angiography were included in standard evaluations. Additional blood tests for coagu-
lopathy or prothrombotic conditions were performed in patients younger than 45 years old.
Transesophageal echocardiography was included in the standard evaluation, except in patients
with decreased consciousness, impending brain herniation, poor systemic condition, inability to
accept an esophageal transducer because of swallowing difficulty or tracheal intubation, or lack of
informed consent [17]. Transthoracic echocardiography, heart CT, and Holter monitoring were
also performed in selected patients [18]. Most patients were admitted to the stroke unit and moni-
tored continuously with EKG during their stays. For this study, we included consecutive patients
admitted from Jan 2001 to June 2007. When a patient was admitted more than twice because of
recurrent strokes, only data for the first admission were used for this study.
Risk factor definitions
Hypertension was defined as resting systolic blood pressure140 mm Hg or diastolic blood
pressure90 mm Hg after repeated measurements during hospitalization or currently taking
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antihypertensive medication. Diabetes mellitus was defined as fasting plasma glucose values
7 mmol/L or taking an oral hypoglycemic agent or insulin. Hyperlipidemia was diagnosed as
a fasting serum total cholesterol level6.2 mmol/L, low-density lipoprotein cholesterol4.1
mmol/L, or currently taking a lipid-lowering drug after a hyperlipidemia diagnosis. A current
smoker was defined as an individual who smoked at the time of stroke or had quit smoking 1
year prior to treatment [19].
Stroke subtype classification
Stroke classifications were determined during weekly conferences based on the consensus of
stroke neurologists. Data including clinical information, risk factors, imaging study findings,
laboratory analyses, and other special evaluations were collected. Along with these data, prog-
nosis during hospitalization and long-term outcomes were also determined. Data were entered
into a web-based registry. Stroke subtypes were identified according to the Trial of ORG 10172
in Acute Stroke Treatment (TOAST) classification [20]. We defined CS as strokes of undeter-
mined etiology attributable to negative evaluation despite extensive work-up.
Neuroimaging protocol
MRI examinations were performed on either a 1.5T (Signa Horizon 1.5T 85, GE Medical Sys-
tem, Milwaukee, Wis; or Intera 1.5T, Philips Medical Systems, Best, Netherlands) or a 3.0T
MRI system (Achieva 3.0T, Philips Medical Systems, Best, the Netherlands). Patients under-
went MRI within 3 days after admission according to the following parameters. For diffusion-
weighted imaging: repetition time (TR)/echo time (TE) = 2,600–6,500/42–70 milliseconds,
2-mm interslice gap, field of view (FOV) = 230 X 230 mm, slice thickness = 5 mm, 6 different
diffusion gradient directions (x, y, z, xy, yz, zx), and 2 b values (0, 1,000); for fluid-attenuated
inversion recovery: TR/TE = 9,000/120 milliseconds, pixel spacing = 0.449 mm/0.449 mm,
FOV = 230 X 230 mm, and slice thickness = 5 mm.
Image review and analysis
WMH were assessed on FLAIR images in the supra tentorium according to the Standards for
Reporting Vascular Changes on Neuroimaging criteria [21]. WMH was graded according to the
Fazekas scale, which has been widely used for rating WMH [22]. We graded WMH in the hemi-
sphere contralateral to acute stroke because WMH may overlap with the acute infarction area.
When a patient had bilateral small infarctions, the less-involved hemisphere was measured [23].
Using visual assessment of FLAIR images, we further categorized WMH into periventricular and
deep WMH. Periventricular WMH indicated WMH exclusively located around the lateral ventri-
cles (0: absent, 1: caps or pencil lining, 2: smooth halo, 3: irregular periventricular WMH extending
into deep white matter). Deep WMH denoted WMH in the centrum semiovale and the corona
radiata (0: absent, 1: punctate foci, 2: beginning confluence of foci, 3: large confluent areas). Total
WMH score was calculated by summing the scores for periventricular WMH and deep WMH,
and ranged between 0 and 6. WMH degree was trichotomized into no (Fazekas score = 0), mild
(Fazekas score = 1 to 2), and severe (Fazekas score = 3 to 6). Two investigators blinded to clinical
information reviewed the MRI and rated WMH degree. Inter-rater reliability between investiga-
tors was excellent (κ values = 0.842 for periventricular WMH and 0.798 for deep WMH).
According to the TOAST classification, CS patients should not have greater than 50% ath-
erosclerosis in the relevant artery. Therefore, we defined atherosclerotic lesions of less than
50% as mild atherosclerosis. We classified the study cohort into four groups based on the loca-
tion of arterial stenosis: (1) intracranial (IC), which included patients who had stenotic lesions
in the IC internal carotid arteries, the IC vertebral arteries, the basilar artery, proximal portion
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of the middle cerebral arteries, the anterior cerebral arteries and the posterior cerebral arteries
without significant stenosis in extracranial (EC) arteries; (2) EC, which included patients with
stenotic lesions in EC arteries, such as the proximal internal carotid arteries or the EC vertebral
arteries; (3) mixed, which included patients with stenotic lesions in both IC and EC arteries;
and (4) non-stenosis [24].
Follow-up and outcome measures
Surviving patients were followed in outpatient clinic or by a structured telephone interview at
3 months and every year after discharge. Short-term functional outcomes at 3 months were
determined based on the modified Rankin Scale. Poor outcome was defined as a modified
Rankin Scale (mRS) score3. Pre-stroke mRS score was not measured. Deaths among sub-
jects from January 2001 to December 31, 2013 were confirmed by matching the information in
the death records and identification numbers assigned to the subjects at birth [25]. We
obtained data for the date and causes of death from the Korean National Statistical Office,
which were identified based on death certificates. The causes of death were coded according to
the ICD-10. Cardiovascular death included fatal stroke (I60–64) and fatal ischemic heart dis-
ease caused by myocardial infarction (I21–23, I46).
Standard protocol approvals, registrations, and patient consents
The institutional review board of Severance Hospital, Yonsei University Health System,
approved this study and waived the patients’ informed consent because of a retrospective
design and observational nature of this study.
Statistical analysis
SPSS for Windows (version 23, SPSS, Chicago, IL, USA) was used for statistical analysis. The
Pearson χ2 test was used to compare frequencies. For continuous variables, normality was
examined using the Kolmogorov-Smirnov test. If the data did not deviate from a normal distri-
bution, the mean and standard deviation were calculated and independent sample t-tests were
used for comparisons. For data that were not normally distributed, we reported descriptive sta-
tistics as the median and interquartile range (IQR) and compared them using the Mann-Whit-
ney U test. Logistic regression analysis was used to identify factors associated with severe
WMH and poor outcomes at 3 months. Survival curves were generated according to the
Kaplan-Meier method and compared using the log-rank test. The Cox proportional hazard
regression analysis was performed to calculate crude and adjusted hazard ratios with 95% CI.
The interaction term (agesevere WMH) was also tested in the regression model. Because age
is a major determinant for WMH, subgroup analysis was performed by dichotomizing using
the median age (64 years). Younger patients were defined as those<65 years old and older
patients were65 years old. Stroke severity was stratified on the basis of NIHSS as follows:
mild (0–5), moderate (6–14) and severe (15) [26]. All parameters that were significant in the
univariable analysis (p<0.1) and possible confounding factors including age and gender were
included in the multivariable model. Statistical significance was set at p<0.05.
Results
Patient enrollments and stroke etiology evaluation
Total of 2732 patients were registered in the stroke registry during the study period. After
excluding 201 patients with TIA and 1932 patients with non-cryptogenic stroke, a total of 599
patients (21.9%) were classified as having CS. Among them, 104 patients (17.4%) who
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underwent different protocols and 260 (43.4%) patients who did not undergo comprehensive
cardiac evaluations were excluded. Demographic characteristics of excluded CS patients were
not different except for age and the proportion of female (described in S1 Table). Finally, 235
patients were enrolled in the study (Fig 1). Angiographic evaluations of supra-aortic trunks
were performed for all patients.
Demographic data and factors associated with severe white matter
hyperintensities
The median age was 63 (IQR, 54–69 years) and 32.3% were woman. Among the enrolled
patients, 214 patients (91.1%) had WMH and 21 patients (8.9%) did not have WMH. Degree
Fig 1. Patient flow chart. WMH indicates white matter hyperintensities; LAA, large artery atherosclerosis; CE, cardioembolism; LAC, lacune; SOD,
stroke of other determined etiology; UM, stroke of undetermined etiology because of multiple causes; UI, stroke of undetermined etiology because of
incomplete evaluation.
https://doi.org/10.1371/journal.pone.0196014.g001
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of WMH was severe in 81 patients (34.5%) and mild in 236 patients (56.6%). Degree of WMH
in the periventricular area was correlated with that of deep white matter (correlation coeffi-
cient = 0.773, p<0.001). When comparing patients with no or mild WMH, those with severe
WMH were older, more likely to be woman, less likely to be current smoker, more frequently
had histories of hypertension, and cerebral artery atherosclerosis. Mild cerebral artery athero-
sclerosis (arterial stenosis <50%) was found in 55.3% of patients. Cerebral artery atherosclero-
sis is correlated with degree of WMH (p <0.001), especially in IC atherosclerosis (Table 1). In
univariable analysis, old age, woman, hypertension, smoking, and intracranial or combined
atherosclerosis in both IC and EC were associated with severe WMH. In multivariable logistic
regression analysis, old age, hypertension, and IC or combined atherosclerosis in both IC and
EC were independently associated with severe WMH (described in S2 Table).
Functional outcomes at 3 months
Poor functional outcomes at 3 months were more common in those with severe WMH (Fig 2).
In multivariable analysis, initial NIHSS and severe WMH were independent predictors of
poor functional outcome at 3 months. CS patients with severe WMH were 5.25 times (95% CI,
2.07–13.31) more likely to have poor outcomes at 3 months compared to those without
(Table 2). The interaction term indicated that age was not a significant modifier of the rela-
tionship between short-term functional outcome and WMH severity (P = 0.209).
Cumulative death rates
Study patients were followed-up for a median of 7.7 years (IQR, 6.7–9.0). During the follow-
up period, 64 (27.2%) patients died. The cumulative death rates were 4.3% within 1 year,
Table 1. Demographic characteristics.
Total (N = 235) White matter hyperintensity P value†
No (N = 21) Mild (N = 133) Severe (N = 81)
Age, y, median [IQR] 63 [54–69] 47 [43–54] 61 [54–66] 69 [63–74] <0.001
< 65 133 (56.6) 20 (95.2) 89 (66.9) 24 (29.6)
65 102 (43.4) 1 (4.8) 44 (33.1) 57 (70.4)
Sex, woman 76 (32.3) 6 (28.6) 34 (25.6) 36 (44.4) 0.004
Hypertension 178 (75.7) 13 (61.9) 95 (71.4) 70 (86.4) 0.006
Diabetes mellitus 72 (30.6) 8 (38.1) 37 (27.8) 27 (33.3) 0.52
Hyperlipidemia 13 (5.5) 0 (0) 6 (4.5) 7 (8.6) 0.13
Smoking 118 (50.2) 12 (57.1) 79 (59.4) 27 (33.3) <0.001
NIHSS, median [IQR] 3 [1–6] 2 [1–5] 3 [1–6] 3 [1–7] 0.44
Mild (0–5) 172 (73.2) 16 (76.2) 98 (73.7) 58 (71.6)
Moderate (6–14) 56 (23.8) 4 (19.0) 33 (24.8) 19 (23.5)
Severe (15) 7 (3.0) 1 (4.8) 2 (1.5) 4 (4.9)
Cerebral artery
atherosclerosis
130 (55.3) 7 (33.3) 60 (45.1) 63 (77.8) <0.001
None 105 (44.7) 14 (66.7) 73 (54.9) 18 (22.2)
Intracranial 61 (26.0) 4 (19.0) 28 (21.1) 29 (35.8) 0.013
Extracranial 23 (9.8) 3 (14.3) 15 (11.3) 5 (6.2) 0.18
Combined 46 (19.6) 0 (0) 17 (12.8) 29 (35.8) <0.001
IQR indicates interquartile range; NIHSS, NIH Stroke Scale
Values are n (%)
† Comparison between severe WMH and others.
https://doi.org/10.1371/journal.pone.0196014.t001
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11.5% within 3 years, and 17.9% within 5 years. Cumulative death rates were higher in patients
with severe WMH than in those with no or mild WMH (7.4% vs. 2.6% within 1 year, 17.3% vs.
8.4% within 3 years, 28.4% vs. 12.3% within 5 years) (Fig 2).
Univariable and multivariable analyses of long-term mortality
Kaplan-Meier survival analysis revealed that all-cause mortality and cardiovascular mortality
were higher in patients with severe WMH compared to those with no or mild WMH (Fig 3).
In Cox regression analyses, old age, woman, and initial stroke severity were independent pre-
dictors of long-term mortality in CS patients. CS patients with severe WMH showed a ten-
dency toward a higher mortality (HR 1.72, P = 0.06). Rather, there was a significant interaction
between age and the severity of WMH on long-term mortality, whereby the impact of WMH
on survival was moderated by age with a negative coefficient (unstandardized beta = -0.057,
SE = 0.029, P for interaction = 0.036 for long-term mortality). It means that impact of WMH
on long-term mortality was influenced by age. (Table 3).
Subgroup analysis for long-term mortality according to age
We further investigated the impact of WMH on long-term mortality in CS patients according
to age. Severe WMH was more common in older patients (65 years) than younger patients
(<65 years) (55.9% vs. 18.0%). Kaplan-Meier survival analysis of younger patients showed that
more patients with severe WMH died during follow-up compared to those with no or mild
WMH (p<0.001). In contrast, there was no difference in survival rate in older patients with
severe WMH (p = 0.46) (Fig 3). Among younger patients, Cox regression analysis revealed
that initial stroke severity, diabetes mellitus, and the presence of severe WMH were indepen-
dent predictors of long-term mortality (HR 3.11, 95% CI, 1.29–7.50). In contrast, there was no
association between severe WMH and long-term mortality among older patients (HR 1.19,
95% CI, 0.63–2.23) (Table 4). Cox regression survival analysis revealed that the severity of
WMH was independent predictors of cardiovascular in younger CS patients, but not in older
CS patients (described in S3 Table).
Fig 2. Functional outcomes at 3 months and cumulative death rate. WMH indicates white matter hyperintensities; mRS, modified Rankin Scale.
https://doi.org/10.1371/journal.pone.0196014.g002
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Table 2. Logistic regression analysis for poor outcome at 3 months (mRS score 3–6).
Unadjusted OR (95% CI) P value Adjusted OR (95% CI) P value
Age† 1.01 (0.98–1.04) 0.636 0.98 (0.94–1.02) 0.29
Woman 1.91 (1.00–3.62) 0.05 1.36 (0.59–3.15) 0.47
Hypertension 1.02 (0.49–2.11) 0.96
Diabetes mellitus 1.53 (0.79–2.94) 0.20
Hyperlipidemia 2.46 (0.77–7.88) 0.13
Smoking 0.66 (0.35–1.24) 0.19
Initial NIHSS† 1.39 (1.27–1.53) <0.001 1.40 (1.27–1.55) <0.001
Cerebral arteryatherosclerosis
None 1 (Reference) NA
Intracranial 1.30 (0.61–2.77) 0.49
Extracranial 0.84 (0.26–2.74) 0.78
Combined 1.11 (0.48–2.60) 0.81
Severe WMH 3.53 (1.85–6.74) <0.001 5.25 (2.07–13.31) <0.001
mRS indicates modified Rankin Scale; OR, odd ratio; NIHSS, NIH Stroke Scale; NA, not applicable; WMH, white matter hyperintensity
† Continuous variables
https://doi.org/10.1371/journal.pone.0196014.t002
Fig 3. Kaplan-Meier survival analysis. The small vertical ticks on the curves indicate censored patients. WMH indicates white matter hyperintensities.
https://doi.org/10.1371/journal.pone.0196014.g003
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Discussion
In this study, we demonstrated that 1) severe WMH was substantial in CS patients, 2) accom-
panying severe WMH was independently associated with short-term outcome in CS patients,
and 3) the impacts of white matter hyperintensities on long-term outcomes in CS patients
were different according to age. Younger CS patients with severe WMH had higher death rates
compared to those with no or mild WMH, but the same distinction was not seen in older
Table 3. Multivariable analysis for survival predictors.
Unadjusted HR (95% CI) P value Adjusted HR (95% CI) P value Adjusted HR for Interaction model (95% CI) P value
Age† 1.07 (1.04–1.10) <0.001 1.07 (1.04–1.10) <0.001 1.10 (1.06–1.14) <0.001
Woman 0.85 (0.50–1.46) 0.56 0.41 (0.23–0.73) 0.003 0.42 (0.23–0.75) 0.003
Hypertension 1.39 (0.74–2.60) 0.31
Diabetes mellitus 1.86 (1.13–3.06) 0.01 1.61 (0.96–2.68) 0.07 1.56(0.92–2.62) 0.10
Hyperlipidemia 1.11 (0.40–3.05) 0.84
Smoking 0.67 (0.41–1.11) 0.12
Initial NIHSS† 1.09 (1.03–1.14) 0.001 1.12 (1.06–1.19) <0.001 1.12 (1.05–1.18) <0.001
Cerebral artery atherosclerosis
None 1 (Reference) NA 1 (Reference) NA 1 (Reference) NA
Intracranial 1.26 (0.69–2.32) 0.45 0.87 (0.46–1.65) 0.67 0.89 (0.47–1.69) 0.72
Extracranial 0.53 (1.60–1.75) 0.30 0.31 (0.09–1.08) 0.07 0.31 (0.09–1.11) 0.07
Combined 1.87 (1.02–3.44) 0.04 1.01 (0.52–1.99) 0.97 1.02 (0.52–2.01) 0.95
Severe WMH 2.84 (1.73–4.67) <0.001 1.72 (0.97–3.04) 0.06 79.82 (1.76–3627.97) 0.02
Agesevere WMH 0.94 (0.89–1.00) 0.047
HR indicates hazard ratio; NIHSS, NIH Stroke Scale; NA, not applicable; WMH, white matter hyperintensity
† Continuous variable
https://doi.org/10.1371/journal.pone.0196014.t003
Table 4. Multivariable analysis for survival predictors according to age.
Young age patients (Age < 65 y) Old age patients (Age 65 y)
Unadjusted HR (95%
CI)
P value Adjusted HR (95%
CI)
P value Unadjusted HR (95%
CI)
P value Adjusted HR (95%
CI)
P value
Age† 1.09 (1.01–1.17) 0.02 1.07 (0.99–1.16) 0.08 1.07 (1.02–1.13) 0.01 1.08 (1.02–1.14) 0.01
Woman 0.43 (0.13–1.46) 0.18 0.44 (0.13–1.53) 0.20 0.84 (0.45–1.56) 0.57 0.54 (0.27–1.06) 0.07
Hypertension 1.04 (0.41–2.66) 0.93 1.40 (0.59–3.32) 0.45
Diabetes mellitus 2.57 (1.11–5.93) 0.03 2.71 (1.09–6.74) 0.03 1.56 (8.36–2.91) 0.16
Hyperlipidemia 1.95 (0.45–8.33) 0.37 0.68 (0.16–2.80) 0.59
Smoking 0.69 (0.30–1.60) 0.39 0.87 (0.47–1.63) 0.67
NIHSS score† 1.11 (1.04–1.20) 0.004 1.11 (1.03–1.19) 0.005 1.09 (1.01–1.17) 0.02 1.10 (1.02–1.19) 0.01
Cerebral
arteryatherosclerosis
None 1 (Reference) NA 1 (Reference) NA
Intracranial 1.14 (0.43–3.03) 0.80 1.09 (0.50–2.41) 0.82
Extracranial 0.34 (0.04–2.58) 0.29 0.85 (0.19–3.76) 0.83
Combined 1.13 (0.32–4.01) 0.85 1.55 (0.73–3.28) 0.25
Severe WMH 4.98 (2.14–11.58) <0.001 3.11 (1.29–7.50) 0.01 1.26 (0.68–2.34) 0.46 1.19 (0.63–2.23) 0.60
HR indicates hazard ratio; NIHSS, NIH Stroke Scale; NA, not applicable; WMH, white matter hyperintensity
† Continuous variable
https://doi.org/10.1371/journal.pone.0196014.t004
WMH affect outcome of cryptogenic stroke patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0196014 April 27, 2018 9 / 15
patients. Because WMH is a chronic process and CS is frequent even in the young patients,
major strength of our study is that we conducted long-term follow-up over 8 years in a large
sample of CS patients.
We found that severe WMH was present in 34.5% of CS patients. Older patients more fre-
quently had severe WMH (55.9%). This finding is in line with those of previous reports that
identified old age as a strong predictor of WMH [27]. Of note, substantial proportion of youn-
ger CS patients also had severe WMH (18.0%). The detection of WMH has been increasing in
the general population as MRI has become more popular. The reported prevalence of WMH
in stroke patients varies among studies, from 6.8% to 44.4% [28, 29]. This variability may
reflect differences in demographic characteristics among study populations including age,
race, ethnicity, and imaging protocols. Our study showed that severe WMH were frequently
found even in younger CS patients. Recent large national study also confirmed that age and
hypertension is major determinant of WMH degree [30].
We presumed the mechanisms of why severe WMH in CS patients with young age was
associated with higher long-term mortality. First, because the mechanism of CS is unknown
and heterogeneous, some CS patients may have atherosclerotic stenosis or paroxysmal atrial
fibrillation, which may bring poor long-term prognosis [2]. In our data, the presence of less
than 50% cerebral artery atherosclerosis, especially in the intracranial artery, was correlated
with severity of WMH. We previously reported that aortic atheroma burden was closely associ-
ated with high degrees of WMH [23]. Considering previous reports of sharing vascular risk
factors between large artery atherosclerosis and WMH [24, 31], severe WMH may be a surro-
gate marker of atherosclerotic burden. High atherosclerotic burden in multiple vascular beds
is known to be associated with poor prognosis in stroke patients [32]. Second, the presence of
severe WMH may imply hidden cardioembolic sources. Severe WMH is associated with atrial
fibrillation, patent foramen ovale, or atrial septal aneurysm [33, 34]. Long-term monitoring of
the heart rhythm can identify paroxysmal atrial fibrillation in up to 16% of patients with CS
[35]. Considering the patients with cardioembolism have the worst outcomes, it may substan-
tially increase the risk for stroke recurrence and long-term mortality. Third, we demonstrated
that severe WMH was an independent predictor of short-term outcomes in CS patients.
Because poor short-term prognosis is a major determinant of long-term outcome [36]. poor
short-term outcomes in CS patients with severe WMH may lead to higher long-term mortality.
Fourth, as younger patients are less likely to have comorbidities other than stroke, higher
WMH burden may suggest brain vulnerabilities in younger CS patients. Our study revealed
that the severity of WMH was independent predictors of cardiovascular mortality in younger
CS patients, but not of non-cardiovascular mortality. In line with our findings, recent reports
suggest the presence of severe WMH in young stroke patients may indicate accelerated cere-
bral aging, which may in turn indicate increased vulnerability to vascular risk factors [37]. In
contrast, our study showed that older patients had similar cardiovascular and non-cardiovas-
cular mortality rates whether they had severe WMH or not. Since elderly people are likely to
die with multiple comorbidities, the association between severe WMH and long-term mortal-
ity rates may be diluted. Other possible explanations include higher stroke recurrence rates,
poor drug compliance, and lower motivation levels regarding life style modifications in elderly
patients. Taken together, the finding of this study suggested that WMH burden may be an
appropriate surrogate imaging marker to determine long-term outcome especially in younger
CS patients. To confirm the exact mechanisms of long-term outcomes in CS patients with
WMH, a prospective long-term follow-up study is needed.
We found that stroke recovery at 3 months was poor in CS patients with severe WMH. The
mechanisms underlying the influence of WMH on short-term functional outcomes are also
needed to define. There are several hypotheses. First, patients with severe WMH were 1.5
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times more likely to have stroke recurrence within 90 days [29]. Symptomatic or asymptomatic
stroke recurrence is highly associated with short-term functional recovery. Second, WMH
regions have reduced vascular density and cerebral blood flow, which may lead to infarct
growth after ischemic events during the acute period [38]. Third, the presence of dysfunctional
neuronal connectivity in patients with WMH can lead to poor recovery after stroke. Neuro-
pathological studies showed decreased neuronal connectivity in WMH areas where pathologi-
cal findings included demyelination, loss of axons and oligodendrocytes, and astrocytic gliosis
in white matter [39]. This may result in decreased functional connectivity between distant cor-
tical regions [40]. Taken together, these lines of evidence indicate that severe WMH may
impair plasticity and recovery after ischemic stroke. Fourth, because WMH is closely associ-
ated with cognitive dysfunction, post stroke depression, decreased motivation, and poor coop-
eration during rehabilitation, it may also affect stroke outcomes [8, 21, 41, 42].
Our study has several limitations. First, there is a possibility of selection bias due to the ret-
rospective design. Therefore, we enrolled consecutive ischemic stroke patients and conducted
long-term follow-up. Depth of cardiac evaluation and presence of hidden cardioembolic
source may influence the results. Second, 76.3% of stroke had NIHSS 0–5. Although NIHSS is
a major predictor of poor stroke outcome, the stroke severity is usually mild in CS patients
than other stroke subtypes. Also, there were only 4 deaths within 30 days in our study. This
poses the possibility that stroke patients with early mortality who were CS patients might have
been excluded because they had no chance of etiology evaluation such as cardiac evaluation
and brain MRI. Therefore, further large study is needed to include severe stroke patients.
Third, young patients with extensive WMH could also have another underlying pathophysiol-
ogy of WMH, for example hereditary SVD [8]. We didn’t consider such etiologies of WMH
and it might have influenced our results. Fourth, our patient cohort was entirely of East Asian
descent. Studies for different ethnicities are needed.
Conclusions
We demonstrated that severe WMH in CS patients is associated with poor short-term func-
tional outcomes. The impacts of WMH on long-term outcomes in CS patients with WMH dif-
fered according to age. Younger CS patients with severe WMH had higher death rates
compared to those with no or mild WMH, whereas the same distinction was not found in
older patients. Taken together, WMH grading might be an age specific prognostic marker in
CS patients.
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